Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

121 results about "Polymixiiformes" patented technology

At present they are classified in their own order Polymixiiformes, but as Nelson says, "few groups have been shifted back and forth as frequently as this one". For instance, they have previously been classified as belonging to the Beryciformes. They are of little economic importance. They are ...

Compositions for manufacturing fiber-reinforced, starch-bound articles having a foamed cellular matrix

Compositions, methods, and systems for manufacturing articles, particularly containers and packaging materials, having a fiber-reinforced, starch-bound cellular matrix. Suitable mixtures used to form the articles are prepared by first preparing a viscous preblended mixture comprising water, a gelatinized starch-based binder, and fibers having an average length greater than about 2 mm. The highly viscous preblended mixture effectively transfers the shearing forces of the mixer to the fibers. The final moldable mixture is then prepared by mixing into the preblended mixture the remaining starch-based binder, water, and other desired admixtures, e.g., mold-releasing agents, inorganic filler rheology-modifying agents, plasticizers, coating materials, and dispersants, in the correct proportions to form an article which has the desired performance criteria. The moldable mixtures are heated between molds at an elevated temperature and pressure to produce form-stable articles having a desired shape and a selectively controlled foamed structural matrix. The articles may be manufactured to have properties substantially similar to articles presently made from conventional materials like paper, paperboard, polystyrene, plastic, or other organic-based materials and have especial utility in the mass-production of containers, particularly food and beverage containers.
Owner:EARTHSHELL SPE

Multi-chamber mixing ampoule

The present invention provides a multi-compartment ampoule for the storage of the separated components of a multiple component mixture and then mixing them together in a single ampoule. The ampoule housing has a proximal dispensing end. The distal end of the ampoule housing is sealed by an end plug configured with an axial through bore. A portion of an axially displaceable plunger element passes thorough the axial through bore and extends into the interior volume and is fixedly attached to an axially displaceable piston element slideablely deployed within the ampoule housing so as to sealingly divide the interior volume into at least first and second storage regions that are pre-filled with the separate components that will be mixed together just prior to use. Axial displacement of the plunger element, and thereby the piston element, in a first direction discharges a first component of the mixture from the distal storage region through a one-way flow configuration into the proximal storage region. After the two components are in a single storage region, they may be thoroughly mixed together. Once the components are mixed, dispensing of the mixture may be by any number of methods. The mixture may be dispensed as if from a standard ampoule, wherein the needle of a syringe is inserted through the sealing membrane and the prescribed amount of the mixture is drawn out. Alternatively, the ampoule may be inserted into an injection device, such as an injection pen for example, in a manner similar to a standard ampoule. The additional features of a needle cannula configured for attachment directly to the proximal dispensing end of the ampoule housing and graduated markings on the shaft of the plunger that are indicative of volume dispensation combined with the basic ampoule provides an embodiment that can store the separated components of the mixture before use, provide a way of mixing the components together in the same ampoule and that can be used as the syringe to dispense the mixture directly into the patient.
Owner:HAIMI SHLOMO +1

Novel granulation process

One of the objects of the invention relates to a pharmaceutical composition in the form of a granulate, wherein the granulates comprises an active pharmaceutical ingredient (API) having a poor water solubility intimately associated with at least one pharmaceutically acceptable sugar, and optionally or preferably at least one pharmaceutically acceptable excipient other than the at least one pharmaceutically acceptable sugar, wherein the active pharmaceutically ingredient has a water solubility less than about 20 mg/ml. The at least one pharmaceutically acceptable excipient other than the at least one pharmaceutically acceptable sugar is selected from the group consisting of disintegrants, wetting agents, diluents, binders, lubricants, glidants, coloring agents and flavoring agents. The at least one pharmaceutically acceptable sugar is preferably selected from pyranosyl pyranoses, such as lactose. Another object of the invention relates to a process for preparing a pharmaceutical granulate, comprising (a) combining an API having poor water solubility with a solution comprising at least one pharmaceutically acceptable sugar, for example a pyranosyl pyranose such as lactose, and a solvent, and optionally at least one pharmaceutically acceptable excipient other than the at least one pharmaceutically acceptable sugar to form a combined mixture; (b) drying the combined mixture of step (a); and (c) comminuting the product of step (b) to obtain the granulate.
Owner:TEVA PHARM USA INC

Novel pharmaceutical granulate

One of the objects of the invention relates to a pharmaceutical composition in the form of a granulate, wherein the granulates comprises an active pharmaceutical ingredient (API) having a poor water solubility intimately associated with at least one pharmaceutically acceptable sugar, and optionally or preferably at least one pharmaceutically acceptable excipient other than the at least one pharmaceutically acceptable sugar, wherein the active pharmaceutically ingredient has a water solubility less than about 20 mg/ml. The at least one pharmaceutically acceptable excipient other than the at least one pharmaceutically acceptable sugar is selected from the group consisting of disintegrants, wetting agents, diluents, binders, lubricants, glidants, coloring agents and flavoring agents. The at least one pharmaceutically acceptable sugar is preferably selected from pyranosyl pyranoses, such as lactose. Another object of the invention relates to a process for preparing a pharmaceutical granulate, comprising (a) combining an API having poor water solubility with a solution comprising at least one pharmaceutically acceptable sugar, for example a pyranosyl pyranose such as lactose, and a solvent, and optionally at least one pharmaceutically acceptable excipient other than the at least one pharmaceutically acceptable sugar to form a combined mixture; (b) drying the combined mixture of step (a); and (c) comminuting the product of step (b) to obtain the granulate.
Owner:TEVA PHARM USA INC

Secondary Fuel Premixing Controller for an Air Intake Manifold of a Combustion Engine

A secondary fuel premixing controller for introducing a secondary fuel into an air intake manifold of a primary fuel combustion engine. The controller includes a hollow housing having an air inlet, a main controller body, and an air/secondary fuel mixing outlet connected together in central alignment one to another. The air inlet introduces incoming air into the controller while the air/fuel mixing outlet discharges a blended mixture of secondary fuel and air into an air intake manifold of the running engine. The main controller body includes a secondary fuel manifold positioned centrally within an interior of the controller which supports for axial movement an air pressure valve positioned proximate to the air inlet and a secondary fuel/air blender connected thereto. The secondary fuel manifold also has a secondary fuel inlet formed therethrough connectable at an outer end thereof to a source of secondary fuel, an inner end positioned for sealing engagement with the secondary fuel/air blender. The air pressure valve and secondary fuel/air blender are biased to close and seal the inner end of secondary fuel inlet when the engine is stopped and to open the inner end responsive to engine intake air intake through the controller when the engine is running.
Owner:VONGSATEANCHAI SUPOJ +3
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products